ANI Pharmaceuticals (ANIP) Competitors

ANI Pharmaceuticals (NASDAQ:ANIP) and Lantheus (NASDAQ:LNTH) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, community ranking, risk and valuation.

Do institutionals & insiders hold more shares of ANIP or LNTH?

76.1% of ANI Pharmaceuticals shares are owned by institutional investors. Comparatively, 99.1% of Lantheus shares are owned by institutional investors. 12.7% of ANI Pharmaceuticals shares are owned by company insiders. Comparatively, 1.5% of Lantheus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Do analysts rate ANIP or LNTH?

ANI Pharmaceuticals currently has a consensus price target of $80.13, indicating a potential upside of 27.63%. Lantheus has a consensus price target of $132.67, indicating a potential upside of 64.29%. Given Lantheus' higher probable upside, analysts plainly believe Lantheus is more favorable than ANI Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ANI Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00
Lantheus	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has higher valuation and earnings, ANIP or LNTH?

Lantheus has higher revenue and earnings than ANI Pharmaceuticals. ANI Pharmaceuticals is trading at a lower price-to-earnings ratio than Lantheus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ANI Pharmaceuticals	$674.07M	2.02	$18.78M	-$1.27	-49.43
Lantheus	$1.54B	3.64	$326.66M	$3.52	22.94

Does the MarketBeat Community prefer ANIP or LNTH?

ANI Pharmaceuticals received 97 more outperform votes than Lantheus when rated by MarketBeat users. However, 66.15% of users gave Lantheus an outperform vote while only 64.19% of users gave ANI Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
ANI Pharmaceuticals	Outperform Votes 441 64.19%	Underperform Votes 246 35.81%
Lantheus	Outperform Votes 344 66.15%	Underperform Votes 176 33.85%

Which has more risk and volatility, ANIP or LNTH?

ANI Pharmaceuticals has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, Lantheus has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500.

Does the media refer more to ANIP or LNTH?

In the previous week, Lantheus had 6 more articles in the media than ANI Pharmaceuticals. MarketBeat recorded 12 mentions for Lantheus and 6 mentions for ANI Pharmaceuticals. ANI Pharmaceuticals' average media sentiment score of 1.58 beat Lantheus' score of 1.14 indicating that ANI Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ANI Pharmaceuticals	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Lantheus	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Is ANIP or LNTH more profitable?

Lantheus has a net margin of 28.57% compared to ANI Pharmaceuticals' net margin of -1.28%. Lantheus' return on equity of 44.29% beat ANI Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ANI Pharmaceuticals	-1.28%	15.87%	6.88%
Lantheus	28.57%	44.29%	23.52%

Summary

Lantheus beats ANI Pharmaceuticals on 12 of the 18 factors compared between the two stocks.